Results 181 to 190 of about 80,047 (217)

Using Unbiased Chemical Proteomics Approaches to Explore the Target Landscape of the Resistance Refractory 7-Azaindole MMV022224 in <i><i>Plasmodium falciparum</i></i>. [PDF]

ACS Infect Dis
Syed AJ, Milne R, Corpas-Lopez V, Dey G, Boonyalai N, Wall RJ, Wiedemar N, Montejo L, Nardella F, Wicht KJ, Pasaje CFA, Okombo J, Niles JC, Fidock DA, Lee MCS, Chakrabarti D, Patterson S, Wyllie S.   +17 more
europepmc   +1 more source

Malaria and cancer: common features and interactions. [PDF]

Trends Parasitol
Su XZ, Stadler RV, Teklemichael AA, Xu F, Wu J.   +4 more
europepmc   +1 more source

Synergistic Antimalarial Activity of Alpha-Mangostin Chitosan Alginate Nanoparticles with Chloroquine in Mice Infected with <i>Plasmodium berghei</i>: The Potential of a New Antimalarial Drug Combination. [PDF]

Iran J Med Sci
Tjahjani S, Hermanto F, Muchtaridi M, Aulifa DL, Haq FA.   +4 more
europepmc   +1 more source

Discovery of actinomycin derivatives with improved selectivity against malaria parasites from a Streptomyces culture library. [PDF]

J Antibiot (Tokyo)
Teshima A, Teklemichael AA, Hirata A, Akimoto M, Taniguchi M, Muslimin R, Ogaki S, Ali A, Suzuki T, Mizukami S, Arakawa K.   +10 more
europepmc   +1 more source

Biomedical Properties, Developments and Therapeutic Potential of Sesquiterpenoid Lactones and Natural Compounds. [PDF]

Pharmaceuticals (Basel)
García-Hernández N, Ramírez-Sánchez I, Ordoñez-Razo RM.   +2 more
europepmc   +1 more source

Antiplasmodial Compounds from <i>Eurycoma harmandiana</i> Pierre and <i>Eurycoma longifolia</i> Jack Against Drug-Resistant <i>Plasmodium falciparum</i>: An Integrated In Vitro and In Silico Study. [PDF]

Int J Mol Sci
Konyanee A, Wahab HA, Kamarulzaman EE, Suhaimi AMM, Ismail AG, Chaniad P, Plirat W, Phuwajaroanpong A, Juengwatanatrakul T, Kanchanapoom T, Yusakul G, Punsawad C.   +11 more
europepmc   +1 more source

Experimental Evolution of Reduced Susceptibility to Artemether-Lumefantrine in <i>Plasmodium berghei</i> Following Serial Drug Pressure. [PDF]

J Parasitol Res
Njoroge SM, Kimani SK, Ngonjo TW, Olunga MS, Seng Ete Wambua J, Waithera MW, Wawa HY, Ng Ang A Waweru J.   +7 more
europepmc   +1 more source

Dual plasmepsin IX and X inhibitors are refractory to development of resistance. [PDF]

PLoS Pathog
Favuzza P, Dans MG, Su W, Thompson JK, Hodder AN, Ngo A, Penington JS, Marapana DS, Dziekan JM, Papenfuss AT, de Lera Ruiz M, Coyle R, Lee MCS, McCauley JA, Lowes K, Olsen DB, Sleebs BE, Cowman AF.   +17 more
europepmc   +1 more source

Behavioral factors associated with artemisinin resistance: linking community treatment practices with pfkelch13 mutations in Northern Uganda. [PDF]

Malar J
Thein KZK, Fukuda N, Balikagala B, Yoshida N, Kubo M, Anena B, Anywar DA, Aginya EO, Mita T.   +8 more
europepmc   +1 more source

Gaps in knowledge and use of artemether-lumefantrine among university students in Southwestern Nigeria: A cross-sectional study. [PDF]

PLoS One
Orok E, Olumoko O, Ekada I, Oladunni A.
europepmc   +1 more source